UPDATE 3-GSK dismisses near-term split as new drugs offset falling Advair

* Q4 sales 6.29 bln stg vs consensus 6.25 bln (Adds more on options for consumer health business) reglan relent tofranil purim vancomycin valtrex relent neurontin sporanox stress tea reglan reglan nevirapine valtrex starlix strattera zyvox vancomycin pyrantel pamoate stromectol relent nexium neurobion forte valtrex vancomycin Yahoo to look at strategic alternatives, cut jobs as it pursues spin-off U.S. agencies say 2015 was hottest on record, shatters records A film for disaster movie junkies, it Pennsylvania officials can prosecute Cosby for sex assault: judge Oil prices slump, returning pressure to global stocks